Gengos Andrew

Gengos Andrew is listed in filings as Chief Financial Officer at Terns Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 5, 2026, including purchase activity and sale activity. Recent filings connect the profile to Terns Pharmaceuticals, Inc. (TERN) and LeonaBio, Inc. (LONA). The current snapshot covers public activity from Sep 5, 2024 to May 5, 2026. Reported amounts are shown as $5.1M to $2.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.